This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Direct purchaser, end payor plaintiffs get partial class certification in US antitrust litigation over HIV medication

( September 27, 2022, 21:06 GMT | Official Statement) -- MLex Summary: Direct purchaser and end payor plaintiffs suing Gilead Sciences and others over an alleged scheme to monopolize the supply of HIV treatments have won partial class certification in California federal court. US District Judge Edward Chen's full order, granting in part and denying in part the separate motions for class certification, is under seal.Docket text follows below:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections